FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2810273658> ?p ?o ?g. }

• W2810273658 endingPage "3467" @default.
• W2810273658 startingPage "3456" @default.
• W2810273658 abstract "While highly efficacious in treating rheumatoid arthritis (RA), the approved Janus kinase (JAK) inhibitor, Tofacitinib (Tofa, CP-690 550), has dose-dependent toxicities that limit its clinical application. In this study, we have examined whether a prodrug design that targets arthritic joints would enhance Tofa’s therapeutic efficacy, which may provide an opportunity for future development of safer Tofa dosing regimens. A prodrug of Tofa (P-Tofa) was synthesized by conjugating the drug to the N-(2-hydroxypropyl)methacrylamide (HPMA) copolymer via an acid cleavable carbamate linker. The therapeutic efficacy of a single dose of P-Tofa was compared to the dose-equivalent daily oral administration of Tofa in an adjuvant-induced arthritis (AA) rat model. Saline treated AA rats and age-matched healthy rats were used as controls. Observational analyses support the superior and sustained efficacy of a single dose P-Tofa treatment compared to the dose-equivalent daily Tofa administration in ameliorating joint inflammation. Micro-CT and histological analyses demonstrated that the P-Tofa treatment provided a structural preservation of the joints better than that of the dose-equivalent Tofa. Optical imaging, immunohistochemistry, and fluorescence-activated cell sorting analyses attribute P-Tofa’s superior therapeutic efficacy to its passive targeting to arthritic joints and inflammatory cell-mediated sequestration. In vitro cell culture studies reveal that the P-Tofa treatment produced sustained the inhibition of JAK/STAT6 signaling in IL-4-treated murine bone marrow macrophages, consistent with a gradual subcellular release of Tofa. Collectively, a HPMA-based nanoscale prodrug of P-Tofa has the potential to enhance the therapeutic efficacy and widen the therapeutic window of Tofa therapy in RA." @default.
• W2810273658 created "2018-07-10" @default.
• W2810273658 creator A5013058673 @default.
• W2810273658 creator A5023437328 @default.
• W2810273658 creator A5039832836 @default.
• W2810273658 creator A5046454314 @default.
• W2810273658 creator A5066459425 @default.
• W2810273658 creator A5071311201 @default.
• W2810273658 creator A5074187814 @default.
• W2810273658 creator A5078315294 @default.
• W2810273658 creator A5080984126 @default.
• W2810273658 creator A5083767894 @default.
• W2810273658 creator A5084262507 @default.
• W2810273658 creator A5086105954 @default.
• W2810273658 date "2018-07-02" @default.
• W2810273658 modified "2023-10-12" @default.
• W2810273658 title "Development of a Janus Kinase Inhibitor Prodrug for the Treatment of Rheumatoid Arthritis" @default.
• W2810273658 cites W1989322771 @default.
• W2810273658 cites W1990105300 @default.
• W2810273658 cites W1991354544 @default.
• W2810273658 cites W1999553222 @default.
• W2810273658 cites W2000468514 @default.
• W2810273658 cites W2010561819 @default.
• W2810273658 cites W2026100316 @default.
• W2810273658 cites W2029345237 @default.
• W2810273658 cites W2031092466 @default.
• W2810273658 cites W2035320881 @default.
• W2810273658 cites W2038992287 @default.
• W2810273658 cites W2041413119 @default.
• W2810273658 cites W2045891124 @default.
• W2810273658 cites W2051992129 @default.
• W2810273658 cites W2060483733 @default.
• W2810273658 cites W2060549798 @default.
• W2810273658 cites W2064366944 @default.
• W2810273658 cites W2069302785 @default.
• W2810273658 cites W2095187713 @default.
• W2810273658 cites W2097463789 @default.
• W2810273658 cites W2101217991 @default.
• W2810273658 cites W2103775523 @default.
• W2810273658 cites W2109362076 @default.
• W2810273658 cites W2114633137 @default.
• W2810273658 cites W2114768841 @default.
• W2810273658 cites W2129948300 @default.
• W2810273658 cites W2138609584 @default.
• W2810273658 cites W2145557630 @default.
• W2810273658 cites W2149447280 @default.
• W2810273658 cites W2153414586 @default.
• W2810273658 cites W2164858045 @default.
• W2810273658 cites W2257779930 @default.
• W2810273658 cites W2273452210 @default.
• W2810273658 cites W2365084676 @default.
• W2810273658 cites W2414972866 @default.
• W2810273658 cites W2418132573 @default.
• W2810273658 cites W2584247588 @default.
• W2810273658 cites W2612141088 @default.
• W2810273658 cites W2917800966 @default.
• W2810273658 cites W4290167681 @default.
• W2810273658 doi "https://doi.org/10.1021/acs.molpharmaceut.8b00433" @default.
• W2810273658 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6078779" @default.
• W2810273658 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29966420" @default.
• W2810273658 hasPublicationYear "2018" @default.
• W2810273658 type Work @default.
• W2810273658 sameAs 2810273658 @default.
• W2810273658 citedByCount "19" @default.
• W2810273658 countsByYear W28102736582018 @default.
• W2810273658 countsByYear W28102736582019 @default.
• W2810273658 countsByYear W28102736582020 @default.
• W2810273658 countsByYear W28102736582021 @default.
• W2810273658 countsByYear W28102736582022 @default.
• W2810273658 countsByYear W28102736582023 @default.
• W2810273658 crossrefType "journal-article" @default.
• W2810273658 hasAuthorship W2810273658A5013058673 @default.
• W2810273658 hasAuthorship W2810273658A5023437328 @default.
• W2810273658 hasAuthorship W2810273658A5039832836 @default.
• W2810273658 hasAuthorship W2810273658A5046454314 @default.
• W2810273658 hasAuthorship W2810273658A5066459425 @default.
• W2810273658 hasAuthorship W2810273658A5071311201 @default.
• W2810273658 hasAuthorship W2810273658A5074187814 @default.
• W2810273658 hasAuthorship W2810273658A5078315294 @default.
• W2810273658 hasAuthorship W2810273658A5080984126 @default.
• W2810273658 hasAuthorship W2810273658A5083767894 @default.
• W2810273658 hasAuthorship W2810273658A5084262507 @default.
• W2810273658 hasAuthorship W2810273658A5086105954 @default.
• W2810273658 hasBestOaLocation W28102736582 @default.
• W2810273658 hasConcept C108215921 @default.
• W2810273658 hasConcept C126322002 @default.
• W2810273658 hasConcept C2777575956 @default.
• W2810273658 hasConcept C2778886723 @default.
• W2810273658 hasConcept C71924100 @default.
• W2810273658 hasConcept C98274493 @default.
• W2810273658 hasConceptScore W2810273658C108215921 @default.
• W2810273658 hasConceptScore W2810273658C126322002 @default.
• W2810273658 hasConceptScore W2810273658C2777575956 @default.
• W2810273658 hasConceptScore W2810273658C2778886723 @default.
• W2810273658 hasConceptScore W2810273658C71924100 @default.
• W2810273658 hasConceptScore W2810273658C98274493 @default.
• W2810273658 hasFunder F4320322725 @default.
• W2810273658 hasFunder F4320337355 @default.

• next